PD Dr. Jan Dörrie

Department of Dermatology

Breaking Entry-and Species Barriers: LentiBOOST® Plus Polybrene Enhances Transduction Efficacy of Dendritic Cells and Monocytes by Adenovirus 5 (2022) Strack A, Deinzer A, Thirion C, Schrödel S, Dörrie J, Sauerer T, Steinkasserer A, Knippertz I Journal article Single-Molecule RNA Sequencing Reveals IFN gamma-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus-Positive MCC Cell Lines (2021) Sauerer T, Lischer C, Weich A, Berking C, Vera J, Dörrie J Journal article BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation (2021) Hoyer S, Eberlein V, Schuler G, Berking C, Heinzerling L, Schaft N, Dörrie J Journal article, Original article A chimeric il-15/il-15rα molecule expressed on nfκb-activated dendritic cells supports their capability to activate natural killer cells† (2021) Bosch NC, Martin LM, Voskens C, Berking C, Seliger B, Schuler G, Schaft N, Dörrie J Journal article Analysis of IFN gamma-mediated Transcriptome Changes in Merkel Cell Carcinoma Cell Lines via Nanopore Sequencing (2021) Sauerer T, Lischer C, Berking C, Vera-Gonzalez J, Dörrie J Conference contribution T-cell responses in merkel cell carcinoma: Implications for improved immune checkpoint blockade and other therapeutic options (2021) Gehrcken L, Sauerer T, Schaft N, Dörrie J Journal article, Review article Preclinical evaluation of a combination of checkpoint blockade and dendritic cell vaccination against Merkel cell carcinoma (2021) Sauerer T, Gerer K, Hoyer S, Erdmann M, Berking C, Voll R, Schuler-Thurner B, et al. Conference contribution BRAF and MEK inhibitors affect dendritic cell maturation and T cell stimulation (2021) Hoyer S, Eberlein V, Schuler G, Berking C, Heinzerling L, Schaft N, Dörrie J Conference contribution Network- and systems-based re-engineering of dendritic cells with non-coding RNAs for cancer immunotherapy (2021) Lai X, Dreyer F, Cantone M, Eberhardt M, Gerer KF, Jaitly T, Uebe S, et al. Journal article Step-by-step Improvement of mRNA-electroporated dendritic Cells in a Phase I / II Clinical Study in cutaneous Melanoma Patients: better Survival correlates with a higher Immunoscore and increased Expression of PEBP1 in the Blood (2020) Dörrie J, Schaft N, Gross S, Ostalecki C, Eberhardt M, Vera-Gonzales J, Uslu U, et al. Conference contribution